Novo Nordisk

News

Novo Nordisk undeterred after losing out on Ablynx takeover

After losing out to Sanofi in its pursuit of Belgian biotech Ablynx earlier this week, Novo Nordisk has put a brave face on the disappointment.

News

Omada Health to trial digital diabetes prevention tool

PREDICTS trial will involve 500 patients

News

Europe: thumbs up for Roche's Hemlibra, Chiesi rare disease ...

Drug has been approved in US since November

News

Novo Nordisk must increase Ablynx bid, says shareholder

Novo Nordisk must up its bid to take over Belgian biotech Ablynx, after the company’s largest shareholder reportedly said its 2.6 billion euro ($3.18 billion) offer was too low.

News

Lilly to research real world diabetes with digital health fi...

Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.

News

Novo Nordisk and Celgene lead January pharma M&A

Novo's bid

Novo Nordisk undeterred after losing out on Ablynx takeover

Omada Health to trial digital diabetes prevention tool

Europe: thumbs up for Roche's Hemlibra, Chiesi rare disease ...

Novo Nordisk must increase Ablynx bid, says shareholder

Lilly to research real world diabetes with digital health fi...

Novo Nordisk and Celgene lead January pharma M&A

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Novo Nordisk

Editor's Picks